Breaking News Instant updates and real-time market news.

JPM

JPMorgan

$113.18

2.56 (2.31%)

, WFC

Wells Fargo

$52.55

0.62 (1.19%)

13:56
04/12/18
04/12
13:56
04/12/18
13:56

What to watch in big bank earnings reports

JPMorgan (JPM), Wells Fargo (WFC) and Citigroup (C) are scheduled to report quarterly results on April 13. What to watch for: 1. OUTLOOKS: Back in February, JPMorgan said it expects medium-term ROTCE of about 17%, a CET1 ratio of 11%-12%, a 55% overhead ratio and a 100% net payout ratio. The bank sees U.S. credit, debit card spending growing over 5% per year for the next five years, and said it expects FY18 net interest income to be between $54B-$55B. JPMorgan added it sees FY18 consumer card net charge-offs of 3.25%-3.5%, 2018 core loan growth ex-CIB of 6%-7%, and FY18 adjusted expense lower than $62B. During Wells Fargo's last earnings call, the company said it expects FY18 effective tax rate to be approximately 19% and that it was "on track" with $4B in expense reductions by end of 2019. Additionally, the bank noted it expects FY18 total expenses of $53.5B-$54.5B. Wells Fargo also expects to close 250 branches in 2018, and sees its total branch network declining to 5,000 by 2020. 2. HEALTHCARE JV: On January 30, Amazon (AMZN), Berkshire Hathaway (BRK.A, BRK.B) and JPMorgan announced that they are partnering on ways to address healthcare for their U.S. employees, with the aim of improving employee satisfaction and reducing costs. The three companies will pursue this objective through an independent company that is free from profit-making incentives and constraints. The initial focus of the new company will be on technology solutions that will provide U.S. employees and their families with simplified, high-quality and transparent healthcare at a reasonable cost. Investors will be tuned in to JPMorgan's earnings call to hear if any additional color on this effort is offered. 3. FEDERAL RESERVE SANCTIONS: Responding to recent and widespread consumer abuses and other compliance breakdowns by Wells Fargo, the Federal Reserve Board announced on February 2 that it would restrict the growth of the firm until it sufficiently improves its governance and controls. In addition to the growth restriction, the Board's consent cease and desist order with Wells Fargo requires the firm to improve its governance and risk management processes, including strengthening the effectiveness of oversight by its board of directors. Until the firm makes sufficient improvements, it will be restricted from growing any larger than its total asset size as of the end of 2017. Commenting on the decision, Wells Fargo said it was confident it will satisfy the requirements of the consent order it agreed to with the Board of Governors of the Federal Reserve System. "We take this order seriously and are focused on addressing all of the Federal Reserve's concerns," said Timothy Sloan, Wells Fargo's president and CEO. 4. CRYPTOCURRENCY: Back in February, Bloomberg reported that JPMorgan and Bank of America (BAC) were stopping purchases of Bitcoin and other cryptocurrencies on their credit cards. JPMorgan does not want the credit risk associated with such transactions, the report added, citing spokeswoman Mary Jane Rodgers.

JPM

JPMorgan

$113.18

2.56 (2.31%)

WFC

Wells Fargo

$52.55

0.62 (1.19%)

C

Citi

$71.74

1.845 (2.64%)

BAC

Bank of America

$30.51

0.6132 (2.05%)

AMZN

Amazon.com

$1,427.05

-9.17 (-0.64%)

BRK.A

Berkshire Hathaway

$297,195.00

3946 (1.35%)

BRK.B

Berkshire Hathaway

$197.97

2.75 (1.41%)

  • 12

    Apr

  • 13

    Apr

  • 13

    Apr

  • 13

    Apr

  • 16

    Apr

  • 16

    Apr

  • 20

    Apr

  • 25

    Apr

  • 15

    May

  • 30

    May

  • 13

    Jul

  • 12

    Oct

JPM JPMorgan
$113.18

2.56 (2.31%)

04/02/18
KEYB
04/02/18
NO CHANGE
KEYB
Efforts to strengthen in-store healthcare offering positive for Walmart, says KeyBanc
KeyBanc analyst Edward Yruma notes that the push to provide consumer-driven and lower-cost healthcare continues its push into retail as The Wall Street Journal reports that Walmart (WMT) is in discussions to acquire or develop a closer partnership Humana (HUM). This is on the heels of Amazon's (AMZN) recent JV with Berkshire Hathaway (BRK.A; BRK.B) and JPMorgan (JPM) to provide healthcare for employees, he adds. The analyst views any efforts to strengthen the in-store healthcare offering as a positive for Walmart's stock.
03/22/18
EDJN
03/22/18
UPGRADE
EDJN
Buy
JPMorgan upgraded earlier to Buy from Hold at Edward Jones
04/11/18
04/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL), Apple (AAPL), and Facebook (FB) were initiated with a Buy at Monness Crespi. 2. Caterpillar (CAT) initiated with a Buy at Buckingham. 3. JPMorgan (JPM) initiated with a Hold at HSBC. 4. eBay (EBAY) assumed with an Overweight at KeyBanc. 5. Ericsson (ERIC) initiated with a Hold at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/18
HSBC
04/11/18
INITIATION
Target $111
HSBC
Hold
JPMorgan initiated with a Hold at HSBC
HSBC analyst Alevizos Alevizakos started JPMorgan with a Hold rating and $111 price target. The analyst sees minimal share upside from current valuation levels.
WFC Wells Fargo
$52.55

0.62 (1.19%)

04/05/18
04/05/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Merck (MRK) upgraded to Overweight from Equal Weight at Barclays with analyst Geoffrey Meacham saying he believes the company will continue to take share in first-line lung cancer, driven by positive KN-189 and KN-042 data. 2. Acuity Brands (AYI) upgraded to Outperform from Market Perform at JMP Securities with analyst Joseph Osha saying he believes the stock is finally trading at a "reasonable valuation based on reasonable expectations." 3. AMD (AMD) upgraded to Buy from Hold at Stifel with analyst Kevin Cassidy citing valuation and the company's margin expansion potential. 4. Tiffany (TIF) upgraded to Buy from Hold at Loop Capital with analyst Laura Champine saying her initial meeting with the company's new CEO Alessandro Bogliogo added to her confidence. 5. Citi (C) and Wells Fargo (WFC) were upgraded to Buy from Neutral at UBS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/05/18
UBSW
04/05/18
UPGRADE
Target $60
UBSW
Buy
Wells Fargo upgraded to Buy from Neutral at UBS
UBS analyst Raul Martinez upgraded Wells Fargo (WFC) to Buy while lowering his price target for the shares to $60 from $63. The stock's "substantial" underperformance has created a buying opportunity, Martinez tells investors in a research note. He believes the market is discounting a "sizable" reduction in earnings power versus current estimates. The right sizing of Wells' expense base and capital optimization should eventually help drive improved earnings and profitability, Martinez contends. The analyst this morning also upgraded shares of Citi (C) to Buy from Neutral.
03/06/18
RHCO
03/06/18
INITIATION
Target $25
RHCO
Buy
Cardlytics initiated with a Buy at SunTrust
SunTrust analyst Youssef Squali initiated Cardlytics (CDLX) with a Buy rating and a price target of $25. Squali contends that the discount with which this "leader in the $11B native ad bank market trade" should close once investors become familiar with its "limited inventory, large partnerships and lack of easily identifiable publicly-traded comps", looking beyond the company's longer sales cycle. The analyst also points to Cardlytics pilot partnership with Wells Fargo (WFC) in first party data collection, which could roll out nationwide in 2019 and create more significant revenue growth.
02/21/18
MSCO
02/21/18
NO CHANGE
Target $136
MSCO
Overweight
Morgan Stanley sees JPMorgan turning tax savings into market share gains
Morgan Stanley analyst Betsy Graseck raised her 2022 EPS estimate for JPMorgan (JPM) by 2%, or 34c, stating that she expects the bank to reach top 5 in the 15-20 new markets it previously said it will use a part of its tax savings reinvestments to enter. The 34c in EPS she estimates JPMorgan can add by building out its presence in 20 new markets by 2022 is "far more compelling" than using the same amount of money to buy back stock, which would increase 2022 EPS only 5c, said Graseck. The analyst sees about a third of JPMorgan's new deposit share gains to come from Wells Fargo (WFC) and cut her 2022 EPS forecast for the latter by 1.2%. Graseck keeps an Overweight rating on JPMorgan ahead of the bank's February 27 investor day and increased her price target on the stock to $136 from $133.
C Citi
$71.74

1.845 (2.64%)

04/11/18
04/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Citi (C) upgraded to Buy from Hold at HSBC with analyst Alevizos Alevizakos saying he sees improved profitability in the near-term, driven by U.S. dollar depreciation and tax reform, re-rating the shares higher. 2. BHP Billiton (BHP) upgraded to Buy from Hold at Deutsche Bank with analyst Liam Fitzpatrick saying the shares offer compelling value at current levels. 3. Mattel (MAT) upgraded to Hold from Underperform at Jefferies with analyst Stephanie Wissink saying the company's near-term risks are largely known and priced into the shares. 4. AeroVironment (AVAV) upgraded to Buy from Hold at Stifel with analyst Joseph DeNardi saying he sees the company benefiting from tailwinds including an improving defense budget environment, a heightened global threat environment, and "as strong a pipeline of opportunities" as he has seen in ten years. 5. Helmerich & Payne (HP) upgraded to Market Perform from Underperform at Wells Fargo with analyst Judson Bailey citing strength in the land rig market. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/05/18
UBSW
04/05/18
UPGRADE
Target $80
UBSW
Buy
Citi upgraded to Buy from Neutral at UBS
UBS analyst Raul Martinez upgraded Citi to Buy and raised his price target for the shares to $80 from $78. The risk/reward profile of owning the shares now skews positive, Martinez tells investors in a research note. He believes profitability in Citi's Global Consumer Banking "should grind higher" from current levels, while its capital optimization opportunities "remain considerable." The analyst is also encouraged by better loan growth and earnings momentum at Citibanamex. Martinez notes that Citi shares trade at a discount to all the banks he covers.
04/11/18
HSBC
04/11/18
UPGRADE
Target $85
HSBC
Buy
Citi upgraded to Buy from Hold at HSBC
HSBC analyst Alevizos Alevizakos upgraded Citi to Buy and raised his price target for the shares to $85 from $82. The analyst sees improved profitability in the near-term, driven by U.S. dollar depreciation and tax reform, re-rating the shares higher. He believes the market is not fully appreciating Citi's leading credit card franchise and its growth prospects in Mexico.
BAC Bank of America
$30.51

0.6132 (2.05%)

04/03/18
BMOC
04/03/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America pullback provides a buying opportunity, says BMO Capital
BMO Capital analyst James Fotheringham says that the recent near-10% pullback in the Bank of America stock price provides investors with a buying opportunity. The analyst contends that the bank's stock trades much more closely in line with short term interest rates rather than the 10-year and believes that its net interest margins will prove to be "insensitive" to lower yields on the benchmark as well as higher LIBOR-OIS spreads. Fotheringham keeps his $34 price target and Market Perform rating on Bank of America, adding that its current two-year-forward P/E valuation multiple is close to its long-term historical average.
02/02/18
MSCO
02/02/18
NO CHANGE
MSCO
BofA, JPMorgan, Citi best positioned for tougher CCAR test, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said she had expected an easier stress test from the Federal Reserve but that the 2018 CCAR test actually seems tougher than last year, given the more intense recessions and lower asset prices modeled in it. A tougher test makes her less optimistic on her strong payout growth expectations, said Graseck, who sees Bank of America (BAC), JPMorgan (JPM) and Citi (C) as best positioned to "weather the storm" and increase payouts given their resilient balance sheets and significant excess capital. She sees Goldman Sachs (GS), which recently cut buybacks, as at risk from a tougher test, which likely weighs on the bank's 2018 ask, Graseck added.
01/31/18
DBAB
01/31/18
NO CHANGE
Target $15
DBAB
Sell
GE likely to be dropped from Dow 30 index, says Deutsche Bank
General Electric (GE) is likely to be dropped from the Dow Jones Industrial Average after being in the index of 30 companies for over 110 years as an original member since 1896, Deutsche Bank analyst John Inch tells investors in a research note. The chances that GE could be removed from the Dow are increasing as the company continues to face "substantial challenges," the analyst writes. These include "earnings and cash pressure, tough global power generation markets, aggressive downsizing, shrinking its portfolio, management shake-up and SEC investigations," Inch argues. He sees "headline risk" as the most significant risk factor if GE were to be dropped from the Dow, "potentially amplified by GE's high mix of retail investors." Inch notes that the last major Dow shakeup occurred in September 2003, when American Airlines (AAL), Bank of America (BAC) and Hewlett Packard (HPQ) were removed and Goldman Sachs (GS), Nike (NKE) and Verizon (VZ) were added. Inch has a Sell rating on General Electric with a $15 price target. The shares closed yesterday down 33c to $15.95.
01/18/18
RBCM
01/18/18
NO CHANGE
Target $35
RBCM
Outperform
Bank of America price target raised to $35 from $30 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on Bank of America to $35, citing a "strong all around performance" in Q4 along with the bank's commitment to keeping a low expense and growing top line profile. Cassidy says the bank remains "rate sensitive" and expects some $3.3B in net interest income from a 100bps move in short term rates. The analyst also keeps his Outperform rating on Bank of America, pointing to a positive impact from a stronger U.S. economy on its businesses, along with the return of excess capital, supporting a higher stock price view.
AMZN Amazon.com
$1,427.05

-9.17 (-0.64%)

04/05/18
UBSW
04/05/18
NO CHANGE
UBSW
Amazon contract profitable for USPS, former Postmaster General tells UBS
UBS hosted an expert call with Patrick Donahoe, former Postmaster General at the USPS, given confusion around rhetoric coming out of Washington D.C. regarding Amazon's relationship with the USPS, and press reports indicating this contract expires in October 2018. On the call, Donahoe unequivocally stated that the Amazon contract is profitable for the USPS, UBS said. The firm pointed out that USPS business is primarily split into two areas, namely market-dominant products/"monopoly mail," and competitive products where Amazon would fall. By law, competitive products must cover their costs, including both operating costs associated with the service provided and an allocation of 5.5% of the USPS's institutional/fixed costs, the firm added in a research note this morning.
04/06/18
MKMP
04/06/18
NO CHANGE
Target $96
MKMP
Neutral
Hasbro price target lowered to $96 from $110 at MKM Partners
MKM Partners analyst Eric Handler lowered his price target on Hasbro (HAS) to $96, saying the company's earnings will see a bigger impact from the liquidation of Toys R Us than the previous forecast. The analyst also notes headwinds for the company coming from tight inventory management at mass retailers Wal-Mart (WMT) and Amazon (AMZN). Handler adds that he has broader industry concerns, but sees some mitigating product launches for Hasbro, including a new Nerf brand launch, expanded Baby Alive product lines, continued strength from Marvel, and the possible digital launch of Magic: The Gathering Arena. The analyst keeps his Neutral rating on Hasbro.
04/10/18
PIPR
04/10/18
NO CHANGE
Target $1650
PIPR
Overweight
Amazon mindshare down slightly in Piper's semi-annual teen survey
Piper Jaffray's semi-annual survey of over 6,000 U.S. teens showed a slight decline in Amazon (AMZN) mindshare and that Prime adoption continues across all demographics, analyst Michael Olson tells investors in a research note. Amazon mindshare decreased two percentage points versus the prior survey. At 44% mindshare, however, Amazon has nearly eight times more mindshare than its nearest competitor Nike (NKE), Olson points out. He notes the also survey indicates that the number of U.S. Prime households would be in the high-70M range and growing at a decelerating rate. The analyst reiterates an Overweight rating on Amazon shares with a $1,650 price target.
04/11/18
MONN
04/11/18
INITIATION
Target $2000
MONN
Buy
Amazon.com transferred with a Buy at Monness Crespi
Monness Crespi transferred coverage of Amazon.com with a Buy rating and $2,000 price target.
BRK.A Berkshire Hathaway
$297,195.00

3946 (1.35%)

04/03/18
SBSH
04/03/18
NO CHANGE
SBSH
Buy
No news from GE could be considered good news, says Citi
Outside of a potential investment from Warren Buffett's Berkshire Hathaway (BRK.A), "no news" could be viewed as "good news" for General Electric (GE), Citi analyst Andrew Kaplowitz tells investors in a research note. No significant new "issues" have emerged following the announcement of GE's insurance reserves funding plan, nor in the company's annual filing published in late February, Kaplowitz argues. He believes that the more time passes with no significant new issues emerging, the more investors can gain confidence that new management can fully focus on executing a turnaround. Further, he sees "at least three specific areas in which inflections over the coming year could serve as catalysts to changing the narrative:" improving cash generation, asset sale announcements, and potentially inflecting energy end markets. Kaplowitz keeps a Buy rating on shares of General Electric. The stock closed yesterday down 36c to $13.12.
03/27/18
JEFF
03/27/18
NO CHANGE
Target $36
JEFF
Hold
USG board would likely agree to $45-$52 per share offer, says Jefferies
After taking a closer look at comparable transactions, Jefferies analyst Philip Ng believes a USG (USG) takeout price the board would agree to likely is in the $45-$52 per share range. Saint Gobain is the only logical strategic buyer that could potentially counter with a competitive offer to Knauf's, Ng tells investors in a research note. The analyst thinks Berkshire (BRK.A) appears to be a willing seller. He keeps a Hold rating on USG with a $36 price target.
02/05/18
BERN
02/05/18
NO CHANGE
BERN
More pronounced risks to drug supply chain from Amazon coalition, says Bernstein
Bernstein analyst Lance Wilkes thinks the risks to the drug supply chain from Amazon (AMZN), JPMorgan (JPM) and Berkshire Hathaway (BRK.A; BRK.B) healthcare joint venture are much more pronounced than risks to traditional MCOs. The analyst thinks the coalition could acquire a transparency PBM, effectively creating an employer PBM Co-op.
BRK.B Berkshire Hathaway
$197.97

2.75 (1.41%)

01/31/18
CHLM
01/31/18
NO CHANGE
CHLM
Amazon consortium could be longer-term health care disruptor, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich says that Amazon (AMZN), Berkshire Hathaway (BRK.A; BRK.B), and JPMorgan (JPM) new company focused initially on technology solutions to provide simplified, high-quality, and transparent healthcare for their employees and families at a reasonable cost could be a longer-term health care disruptor but it may a little premature to jump to conclusions.
01/31/18
FBCO
01/31/18
NO CHANGE
FBCO
No impact on pharma/biotech from Amazon/JPM/Berkshire coalition, says Credit Suisse
Commenting on the news that Amazon (AMZN), JPMorgan (JPM) and Berkshire Hathaway (BRK.A; BRK.B) are partnering to offer healthcare services to their employees, Credit Suisse analyst Vamil Divan says he does not anticipate any impact on the pharmaceutical or biotechnology sectors in the near or immediate term. However, he acknowledged that the biopharma pricing and distribution models include some perverse incentives that could be ripe for potential disruption.

TODAY'S FREE FLY STORIES

SANM

Sanmina

$27.70

0.1 (0.36%)

, CDNS

Cadence Design

$36.75

-0.27 (-0.73%)

19:00
04/23/18
04/23
19:00
04/23/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SANM

Sanmina

$27.70

0.1 (0.36%)

CDNS

Cadence Design

$36.75

-0.27 (-0.73%)

HLX

Helix Energy

$6.24

-0.245 (-3.78%)

TRMB

Trimble

$36.13

-0.44 (-1.20%)

RUSHA

Rush Enterprises

$43.00

-0.3 (-0.69%)

SLM

Sallie Mae

$11.68

0.015 (0.13%)

ZION

Zions Bancorp

$54.27

0.47 (0.87%)

AMP

Ameriprise

$145.45

1.74 (1.21%)

GOOG

Alphabet

$1,067.70

-5.03 (-0.47%)

ZYME

Zymeworks

$12.08

0.095 (0.79%)

TNDM

TNDM

LQ

La Quinta

$19.55

0.09 (0.46%)

BP

BP

$43.92

0.415 (0.95%)

DGICA

Donegal Group

$15.07

-0.11 (-0.72%)

AMTD

TD Ameritrade

$61.21

-0.04 (-0.07%)

WHR

Whirlpool

$150.31

0.885 (0.59%)

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

BRO

Brown & Brown

$26.56

0.6 (2.31%)

ABX

Barrick Gold

$12.93

-0.23 (-1.75%)

OI

Owens-Illinois

$21.76

0.13 (0.60%)

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

CASA

Casa Systems

$29.81

-0.35 (-1.16%)

BBBY

Bed Bath & Beyond

$17.35

0.22 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 12

    Jun

  • 26

    Apr

UAL

United Continental

$70.32

-1.405 (-1.96%)

18:45
04/23/18
04/23
18:45
04/23/18
18:45
Periodicals
United Continental CEO to forego 2017 bonus, Bloomberg reports »

United Continental CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

UAL

United Continental

$70.32

-1.405 (-1.96%)

18:37
04/23/18
04/23
18:37
04/23/18
18:37
Hot Stocks
United Continental chairman Milton will not stand for reelection »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

INFY

Infosys

$17.43

0.05 (0.29%)

18:12
04/23/18
04/23
18:12
04/23/18
18:12
Hot Stocks
Infosys sees FY18 revenue growth trending at 7.2% rate »

Comments from the Infosys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

SFNC

Simmons First National

$28.95

0.2 (0.70%)

18:04
04/23/18
04/23
18:04
04/23/18
18:04
Earnings
Simmons First National reports Q1 core EPS 57c, consensus 52c »

Reports Q1 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 14

    May

  • 24

    Sep

HLX

Helix Energy

$6.24

-0.245 (-3.78%)

18:01
04/23/18
04/23
18:01
04/23/18
18:01
Earnings
Helix Energy reports Q1 EPS (2c), consensus (6c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:50
04/23/18
04/23
17:50
04/23/18
17:50
Hot Stocks
Einhorn says Assured Guaranty has a lot of exposure to Puerto Rico »

Says Assured…

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

17:45
04/23/18
04/23
17:45
04/23/18
17:45
Hot Stocks
Tivity Health falls 19% after Q1 revenue misses estimates »

Shares of Tivity Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 12

    Jun

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

17:42
04/23/18
04/23
17:42
04/23/18
17:42
Earnings
Tivity Health affirms FY18 EPS 2.12-$2.20, consensus $2.16 »

Backs FY18 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 12

    Jun

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:42
04/23/18
04/23
17:42
04/23/18
17:42
Hot Stocks
Greenlight Capital's Einhorn says Assured Guaranty has no room for losses »

Says Assured Guaranty …

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

HD

Home Depot

$177.73

0.68 (0.38%)

, LOW

Lowe's

$84.34

0.71 (0.85%)

17:40
04/23/18
04/23
17:40
04/23/18
17:40
Initiation
Home Depot, Lowe's, Tractor Supply, O'Reilly Automotive, AutoZone, At Home Group, National Vision initiated  »

Home improvement and…

HD

Home Depot

$177.73

0.68 (0.38%)

LOW

Lowe's

$84.34

0.71 (0.85%)

TSCO

Tractor Supply

$61.64

1.33 (2.21%)

ORLY

O'Reilly Automotive

$222.54

1.06 (0.48%)

AZO

AutoZone

$599.45

3.63 (0.61%)

HOME

At Home Group

$34.69

-0.305 (-0.87%)

EYE

National Vision

$31.57

-0.02 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    May

  • 12

    Jun

WBS

Webster Financial

$59.94

0.555 (0.93%)

17:37
04/23/18
04/23
17:37
04/23/18
17:37
Hot Stocks
Webster Financial increases dividend 7c to 33c »

Webster Financial, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SCHW

Charles Schwab

$55.37

0.37 (0.67%)

17:36
04/23/18
04/23
17:36
04/23/18
17:36
Hot Stocks
Charles Schwab chairman Charles Schwab sells 250K shares »

The chairman of brokerage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

NDAQ

Nasdaq

$86.92

-0.52 (-0.59%)

17:36
04/23/18
04/23
17:36
04/23/18
17:36
Periodicals
Nasdaq proposes to let companies pick where their shares trade, Reuters says »

Nasdaq said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:35
04/23/18
04/23
17:35
04/23/18
17:35
Hot Stocks
Greenlight Capital's Einhorn says short Assured Guaranty »

David Einhorn, president,…

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

SFE

Safeguard Scientifics

$12.25

-0.25 (-2.00%)

17:32
04/23/18
04/23
17:32
04/23/18
17:32
Hot Stocks
Safeguard Scientifics enters agreement with Sierra Capital »

Safeguard Scientifics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

17:31
04/23/18
04/23
17:31
04/23/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Epizyme »

Epizyme down 19% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

EROS

Eros International

$11.63

-0.05 (-0.43%)

17:26
04/23/18
04/23
17:26
04/23/18
17:26
Hot Stocks
Mangrove's August says has questions around Eros' receivables »

Says Eros is suing him.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRO

Brown & Brown

$26.56

0.6 (2.31%)

17:24
04/23/18
04/23
17:24
04/23/18
17:24
Earnings
Brown & Brown reports Q1 adjusted EPS 29c, consensus 32c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

CODA

Coda Octopus Group

$4.07

0.12 (3.04%)

17:23
04/23/18
04/23
17:23
04/23/18
17:23
Syndicate
Breaking Syndicate news story on Coda Octopus Group  »

Coda Octopus Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUI

Sun Communities

$91.54

0.25 (0.27%)

17:19
04/23/18
04/23
17:19
04/23/18
17:19
Earnings
Sun Communities reports Q1 EPS 38c, consensus 28c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

EROS

Eros International

$11.63

-0.05 (-0.43%)

17:17
04/23/18
04/23
17:17
04/23/18
17:17
Hot Stocks
Mangrove's August says short Eros International »

Nathaniel August, founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CASA

Casa Systems

$29.81

-0.35 (-1.16%)

17:16
04/23/18
04/23
17:16
04/23/18
17:16
Syndicate
Casa Systems files to sell 7.35M shares of common stock for holders »

Morgan Stanley & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

  • 26

    Apr

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

17:16
04/23/18
04/23
17:16
04/23/18
17:16
Hot Stocks
Breaking Hot Stocks news story on Epizyme 

Epizyme trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SD

SandRidge Energy

$14.86

0.22 (1.50%)

17:15
04/23/18
04/23
17:15
04/23/18
17:15
Hot Stocks
Icahn demands right to inspect certain SandRidge records »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.